Binding of plasma Factor VII/Vlla to the tissue factor (TF) receptor initiates the coagulation protease cascades. TF expression by circulating monocytes is associated with thrombotic and inflammatory complications in a variety of diseases. Transcriptional activation of the human TF gene in monocytic cells exposed to bacterial lipopolysaccharide (LPS) is mediated by binding of c-Rel/p65 heterodimers to a KB site in the TF promoter. Here, we report that a family of anti-inflammatory agents, known as the salicylates, inhibited LPS induction of TF activity and TF gene transcription in human monocytes and monocytic THP-1 cells at clinically relevant doses. Furthermore, sodium salicylate blocked the ISSUE FACTOR (TF) EXPRESSION initiates the coagulation protease cascades, which generates thrombin and leads to fibrin deposition.'.' Aberrant expression of TF is associated with a variety of clinical disorders such as atherosclerosis,3 rheumatoid arthritis: Gram-negative seps~s ,~ and various forms of cancer.'.' In Gram-negative sepsis, endotoxin-induced activation of blood coagulation plays a major role in the development of multiple organ failure by triggering disseminated intravascular coagulation.83y In rabbits, disseminated intravascular coagulation is manifested by administration of TF or endotoxin and is blocked by treatment of the animals with anti-TF antibodies."." In a baboon model of lethal septic shock, an antihuman TF monoclonal antibody prevented coagulopathy and protected against lethality," suggesting that TF plays a significant role in the pathology of this disease.
ISSUE FACTOR (TF) EXPRESSION initiates the coagulation protease cascades, which generates thrombin and leads to fibrin deposition.'.' Aberrant expression of TF is associated with a variety of clinical disorders such as atherosclerosis,3 rheumatoid arthritis: Gram-negative seps~s ,~ and various forms of cancer.'.' In Gram-negative sepsis, endotoxin-induced activation of blood coagulation plays a major role in the development of multiple organ failure by triggering disseminated intravascular coagulation.83y In rabbits, disseminated intravascular coagulation is manifested by administration of TF or endotoxin and is blocked by treatment of the animals with anti-TF antibodies."." In a baboon model of lethal septic shock, an antihuman TF monoclonal antibody prevented coagulopathy and protected against lethality," suggesting that TF plays a significant role in the pathology of this disease.
Monocytes are the only circulating cell type that can express TF.I3 In addition, these cells appear to be the primary source of TF expression in several animal models of sepagent that inhibits induction of TF expression in monocyte~,'~"' has been shown to reduce endotoxin-mediated coagulation in chimpanzee~.'~ Exposure of monocytes to bacterial lipopolysaccharide (LPS) rapidly induces TF gene e x p r e s s i~n . '~. '~ Our laboratory has identified a decameric KB site in the human TF promoter that mediates LPS induction of the TF gene in human monocytic cells. 20 We have shown that this KB site exclusively binds c-Rel/p65 heterodimers that are present in nuclear extracts of LPS-stimulated human monocytes and monocytic THP-1 cells." Nuclear translocation of these c-ReVp65 heterodimers and subsequent binding to the TF KB site are required for transcriptional activation of the TF gene in monocytic cells.2",2'
The NF-KB/Rel family of transcription factors includes pSO(NFKB l), p52(NFKB2), p65(RelA), RelB, v-Rel, c-Rel, and the Drosophila maternal morphogen Dorsal.".2' Cloning of the genes for both ~5 0~~ and ~6 5 '~ revealed a 300-amino acid region which showed a high degree of homology to a region in the proto-oncogene product c-Re1.26 Family members can form homodimers and heterodimers,22,2' and different KB sites selectively bind these transcription factors.27 For example, the TF gene is specifically regulated by a decarneric KB site that binds c-ReVp65 heterodimers,*' whereas expression of many other genes that are inducibly expressed in monocytes is regulated by p50/p65 heterodimers.z2,23 NF-&/Re1 family members are retained in the cytosol by the binding of a group of inhibitor proteins, including IKBcx." Proteolytic degradation of IKBCX is required for activation and nuclear translocation of p50/p65 and c-Rel/p65 heterodimers.
Salicylic acid and its derivatives, commonly termed the salicylates, are a class of nonsteroidal anti-inflammatory drugs (NSAIDs) administered in the treatment of many diseases."."' The acetylated form of salicylic acid, acetylsalicylic acid (commonly known as aspirin), is the most widely used member of the salicylates, which also include sodium salicylate (Nasal), salsalate, diflunisal, and fendosaL3' The effectiveness of low doses of aspirin to reduce inflammation is due, in part, to its ability to inhibit the synthesis and release of prostaglandins by strictly limiting production of the cyclooxygenase prostaglandin H synthase." However, nonacetylated salicylates do not interfere with prostaglandin synthesis" but are still effective anti-inflammatory agents when used at high doses in the treatment of diseases such as rheumatoid arthritis,3',3' suggesting that salicylates may reduce inflammation by other mechanisms. Indeed, salicylates are able to inhibit the activation of neutrophils and prevent their cell-to-cell adhesion during the inflammatory p r o c e~s . ' ' . '~.~~ More recently, Nasal and aspirin were shown to inhibit NF-KB activation in human Jurkat T cells and mouse pre-B cells by preventing proteolytic degradation of 1~B a . l~
In addition, these agents inhibited the transcriptional activation of the human immunodeficiency virus, presumably by blocking the nuclear translocation of NF-KB." Thus, salicylates might control inflammation by inhibiting transcription of various genes encoding inflammatory mediators.
All reagents were tested by Limulus amebocyte lysate assay (BioWhittaker Inc) and contained less than 5 pg/mL endotoxin contamination.
TF activity. Cell pellets were solubilized at 37°C for 15 minutes using 15 mmol/L octyl P-D-glucopyranoside. TF activity was assayed in cell lysates using a one-stage clotting assay as described." Clotting times were converted to milliunits of TF activity by comparison with a standard curve established with purified human brain For reference, a clotting time of 50 seconds corresponds to 1,000 m u of TF activity.
Fluorescence activated cell sorting (FACS).
PBMCs (1 x lo6 cells/mL) were stimulated for 5 hours with 10 ng/mL LPS before incubation of cells for 30 minutes at 4°C with antihuman TF-FITC or MY4-FITC antibodies. Cells were then fixed in 0.5% paraformaldehyde and were analyzed by flow cytometry using a FACScan (Becton Dickinson, San Jose, CA). Live gating on the monocyte population was accomplished using near forward angle and orthogonal light scatter as well as staining with MY4-FITC antibody.
Analysis of TF mRNA. Total cellular RNA, purified using TRI-ZOL reagent (GIBCO-BRL, Gaithersburg, MD) was analyzed by Northern blotting as d e s~r i b e d .~~ A 641-bp human TF cDNA fragment39 was labeled with [a32P]deoxycytidine triphosphate (ICN) using the Prime-It Kit (Stratagene, La Jolla, CA) and was used to determine TF mRNA levels. An egr-l cDNA fragment was kindly provided by E. Adamson (La Jolla Cancer Research Foundation, La Jolla, CA). Blots were rehybridized with the housekeeping genes, glucose-6-phosphate dehydrogenase (a gift from G. Parry, The Scripps Research Institute) or glyceraldehyde 3-phosphate dehydrogenase (G3PDH; Clontech Laboratories, Inc, Palo Alto, CA). Autoradiography was performed at -70°C, using Kodak XAR-5 film with intensifying screens (Eastman-Kodak, Rochester, NY). Band intensites were quantified by densitometric analysis using a Phosphoimager and ImageQuant software (Molecular Dynamics, Sunnyvale, CA) or Personal Densitometer (Molecular Dynamics).
Nuclear run-on. Nuclear run-on assays were performed using a modification of a procedure described previously.'' Cells were unstimulated or LPS (10 pg/mL)-stimulated (for 1 hour) with or without a 15-minute pretreatment with Nasal (10 mmoYL). Cells (5 X 10') were lysed in a homogenizer and nuclei were collected using a sucrose (2.0 m o m ) cushion. Nuclear RNA was labeled using minutes at 37°C. Samples were extracted with phenol/chloroform and were ethanol-precipitated, and nuclear RNA was purified using a G-SO column. Prehybridization, hybridization, and washing of the filters were performed as de~cribed.~" Radioactivity was quantified using a Phosphoimager and TmageQuant software (Molecular Dynamics). Plasmids and trunsfectiuns. TF, G3PDH and tumor necrosis factor-a (TNFcu) cDNAs present in pGEM3Z (Promega Corp), pSP73 (Promega Corp), and pSP64,Iy respectively, were used in the nuclear run-on assays. pTF(-278)LUC contains 278 bp of the human TF promoter cloned upstream of the luciferase reporter gene'" and p(TF),SVLUC contains four copies of the TF KB site cloned upstream of the simian virus 40 promoter encoding the luciferase reporter gene?' Cells were transfected using diethyl aminoethyl-dextran2" and were cultivated for 46 hours before a S-hour stimulation with LPS. Luciferase activity was determined using the Luciferase Assay System (Promega Corp) and Monolight 2010 luminometer (Analytical Luminescence Inc, San Diego, CA). A total of 2 pg of pRSVCAT was used as an internal control to assess transfection efficiencies. Chloramphenicol acetyl transferase activity expressed by pRSVCAT was determined using a diffusion-based assay2" and showed less than a 10% variation between samples (data not shown).
Electrophoretic mobility .ship ussay (EMSA). Nuclear extracts were prepared from 5 X IO" cells as de~cribed?'.~' Protein concentrations in these extracts were I to S mg/mL, as determined by BCA OETH AND MACKMAN protein assay (Pierce, Rockford, IL). An oligonucleotide (Operon Technologies Inc, Alameda, CA) containing the TF KB site (underlined), S'-GTCCCGGAGTTTCCTACCGGG-3', was annealed with a complimentary primer and was radiolabeled using [cu"P]deoxycytidine triphosphate (ICN) as described." Similarly, binding of the transcription factor, EGR-l, was performed using a radiolabeled oligonucleotide (Operon Tech) containing a prototypic EGR-l site (underlined), S'-CCCGGCGCGGGGGCGATTTCGAGTCA-3'.42
Protein-DNA complexes were separated from free DNA probe by electrophoresis through 6% nondenaturing acrylamide gels (Novex, San Diego, CA) in 0.SX Tris borate-EDTA. Band intensites were quantified by densitometric analysis using a Personal Densitometer and ImageQuant software (Molecular Dynamics).
Western blotting. Analysis of k B a protein was performed by Western blotting. THP-I cells were unstimulated or were LPS-stimulated (for 1 hour) with or without a 15-minute pretreatment with various concentrations of Nasal. Cytosolic extracts were electrophoresed on 8% to 16% sodium dodecyl sulfate-polyacrylamide gels (Novex) and were transferred to Hybond-enhanced chemiluminescence (ECL; Amersham Corp, Arlington Heights, IL). I K B~ protein was detected according to the ECL protocol (Amersham Corp) using a 1:2SOO dilution of an I K B~ antiserum kindly provided by W.C. Greene (J. David Gladstone Institute, San Francisco, CA). For personal use only. on October 30, 2017. by guest www.bloodjournal.org From TF activity in PBMCs and monocytic THP-1 cells, whereas ibuprofen and indomethacin had no significant effect (Fig  1) . These results indicated that both nonacetylated and acetylated salicylates inhibited LPS-induced TF expression.
RESULTS

Salicylates inhibit LPS-induced TF expression in human
We next examined the effect of various doses of NaSal on LPS-induced TF activity. Both PBMCs and THP-1 cells were pretreated for 15 minutes with NaSal (0.1 to 10 mmoV L) before LPS stimulation for 5 hours to maximally induce TF activity. NaSal inhibited LPS induction of TF activity in PBMCs and monocytic THP-1 cells in a dose-dependent manner (Figs 2A and B) . Similar results were observed using aspirin and salsalate (data not shown). Time course experiments analyzed the effect of NaSal (10 mmoVL) at different times (2, 5 , 8, and 24 hours) after LPS stimulation. These results showed that NaSal abolished LPS induction of TF activity at all time points examined (data not shown), indicating that NaSal did not act by simply delaying the induction of TF expression.
The level of inhibition after the addition of NaSal at various times before and after LPS stimulation was also examined. LPS induction of TF activity was abolished by preincubating cells with NaSal(10 mmol/L) for between 0 and 120 minutes before LPS stimulation (Fig 3) . In addition, longer preincubation times (60 to 120 minutes) with lower concentrations of NaSal (0.5 to 1.0 mmoVL) did not increase the level of inhibition (data not shown). However, there was a time-dependent loss of inhibitory activity when NaSal was added after LPS stimulation (Fig 3) . The inhibitory activity required the continual presence of NaSal because full LPSinduced TF activity was recovered when NaSal was removed before LPS stimulation (data not shown). The effect of NaSal was not a result of inhibition of procoagulant activity in the one-stage clotting assay, because this inhibitor had no effect 100 Fluorescence Intensity ____) on clotting times when added to cells immediately before harvest (data not shown).
LPS induction of cell-surface TF expression in PBMCs was measured to determine if NaSal inhibited increases in TF protein expression (Fig 4) . PBMCs were pretreated with NaSal (0.1 and 10 mmolJL) for 15 minutes before a 5-hour incubation with or without LPS (10 ng/mL). LPS induction of TF expression was again inhibited in a dose-dependent manner, with complete inhibition at 10 mmoVL (Fig 4) .
To exclude the possibility that inhibition by NaSal was due to toxicity, we examined protein incorporation of 35S-methionine and "S-cysteine in the presence of LPS and various concentrations of NaSal. Incorporation of these radiolabeled amino acids into newly synthesized cellular protein is a general measure of protein synthesis within a population of cells. PBMCs and THP-l cells pretreated with NaSal and then stimulated with LPS showed no significant decrease in protein synthesis at any concentration of NaSal used in these experiments (data not shown). In addition, measurement of cell viability was assessed by MTS conversion to formazan via dehydrogenase enzymes found in metabolically active cells using a calorimetric assay. No reduction in cell viability was observed using LPS and NaSal (data not shown). Trypan blue cell counts also showed no significant reduction in cell viability (data not shown). Taken together, we observed no significant cell toxicity at the concentrations of NaSal and LPS used during the investigation.
NaSal inhibits LPS-induced TF mRNA expression. We next examined if NaSal inhibited LPS induction of TF mRNA. Before LPS stimulation for 2 hours to maximally induce TF mRNA, monocytic THP-1 cells were pretreated for 15 minutes with NaSal at doses ranging from 0.1 to 10 mmol/L. LPS induction of TF mRNA was inhibited in a Labeled nuclear RNA levels were determined by hybridization t o various target cDNAs (GBPDH, TF, and TNFa) and vector controls pSP73, pGEM32, pSP64 (data not shown). The autoradiogram was exposed for 14 days at -8O'C with intensifier screens. The numbers shown below represent band intensities quantified using a Personal Densitometer and ImageQuant software. No hybridization was detected with the other slots (-) . Similar results were observed in two independent experiments.
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Northern blot analysis of TF mRNA expression in THP-1 cells. (A) Total RNA was extracted from THP-l cells exposed t o LPS (10 @g/mL) for 2 hours with or without a 15-minute pretreatment with Nasal at doses ranging from 0.1 t o 10 mmol/L. The control sample was incubated without LPS or Nasal. TF mRNA levels were determined by Northern blot analysis using a radiolabeled human TF cDNA probe. The blot was reprobed t o determine G3PDH mRNA levels as a measure of RNA loading. The position of the TF mRNA is indicated. Band intensities were quantified by densitometric analysis using a Personal Densitometer and ImageQuant software. Normalized levels of TF mRNA are shown. (B) THP-1 cells were exposed t o PMA (50 ng/mL) for 2 hours with or without a 15-minute pretreatment with Nasal 110 mmol/L). Control cells were incubated without PMA or Nasal. EGR-l mRNA levels were determined by Northern blot analysis using a radiolabeled human egr-l cDNA probe. The blot was reprobed t o determine glucose 6-phosphate dehydrogenase mRNA levels as a measure of loading. The position of the EGR-l mRNA is indicated. No significant differences were observed between EGR-l mRNA levels in RNA prepared from PMA-treated cells or Nasal-and PMA-treated cells. Similar results were obtained in an independent experiment. dose-dependent manner by Nasal (Fig SA) . To exclude the possibility that Nasal was a general trancriptional inhibitor of THP-I cells, we analyzed PMA induction of another genc. q r -l , which is regulated by a KR-independent mechanism. The egr-l gene expresses a nuclear phosphoprotein that binds to DNA in a zinc-dependent manner.'" PMA induction of EGR-I mRNA expression was not affected by Nasal Fig 6) . This increase was abolished by pretreating the cells with NaSal (Fig 6) . Similarly. Nasal abolished the LPS-stimulated increase in TNF-a gene transcription (Fig  6 ) . which is also regulated by NF-KB/Rel proteins.U In contrast. the rate of transcription of the housekeeping gene. G3PDH. was not altered by LPS stimulation or NaSal and LPS (Fig 6) .
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To further analyze the Nasal inhibition of TF gene transcription, THP-I cells were transiently transfected with a plasmid, pTF(-278)LUC. which contains 278 bp of the human TF promoter cloned upstream of a luciferase reporter gene, and a plasmid, p(TF),SVLUC, which contains four copies of the TF KB site cloned upstream of the minimal simian virus 40 promoter expressing the luciferase gene. Previous studies have shown that LPS induction of the TF promoter is mediated by an LPS response element (-227 to -172 bp) in the wild-type TF promoter or by tandem copies of the isolated TF KB site.'".'' Before a S-hour LPS stimulation to maximally induce luciferase expression, transfected cells were pretreated for IS minutes with Nasal in doses ranging from 0.1 to IO mmol/L. LPS induction of luciferase activity expressed by pTF(-278)LUC and p(TF),SVLUC was inhibited in a dose-dependent manner by Nasal (Fig 7) . IS minutes with Nasal (0.1 to 10 mmol/L) before a 2-hour LPS stimulation. Nuclear extracts were analyzed by EMSA using a radiolabeled oligonucleotide containing the TF KB site.'' LPS activation of c-ReVp6S heterodimers in THP-I cells was inhibited by Nasal in a dose-dependent manner (Fig 8A) . Nasal also inhibited the LPS activation of NF-~B(pSO/p65) in THP-I cells (data not shown). In addition, Western blots showed that Nasal prevented the reduction in k B a protein in the cytosol I hour after LPS stimulation (Fig 8B) . Similar results were observed in cells stimulated with LPS for 2 hours (data not shown). These results indicated that Nasal inhibited LPS induction of TF gene expression in human monocytic cells by preventing proteolytic degradation of I K B~ protein and nuclear translocation of cRel/p6S heterodimers.
Salicdates inhibit LPS activation
To exclude the possibility that Nasal nonspecifically inhibited protein-DNA interactions. we analyzed the binding of EGR-I to a prototypic EGR-I site using nuclear extracts from THP-I cells with or without Nasal. THP-I cells were pretreated for IS minutes with Nasal ( I O mmollL) before a 2-hour PMA ( S O ng/mL) stimulation. EMSA showed that EGR-I binding activity induced by PMA was not affected by the presence of Nasal (Fig 8C) .
Other NSAIDs, including salsalate, aspirin, ibuprofen, and indomethacin, were examined to determine if these agents also inhibited the activation of c-ReVp65 heterodimers. THP-I cells were pretreated for I S minutes with aspirin ( IO mmol/ L), Nasal ( I O mmol/L), salsalate ( I O mmol/L), ibuprofen (200 pmol/L), or indomethacin (25 pmollL) and then were stimulated with LPS ( I O pg/mL) for 2 hours. Aspirin, Nasal, and salsalate all abolished the nuclear translocation of c-ReV p65 heterodimers, whereas ibuprofen and indomethacin had no effect (Fig 9) . which is consistent with the inability of ibuprofen and indomethacin to inhibit LPS induction of TF activity in monocytic cells (Fig. I) .
Nasal concentrations inhibiting 50% of the LPS-induced TF expression in the different assays (IC,,,) were 0.656 to 1.030 mmol/L (Table I) . Differences in the ICztl may be caused by the different incubation times of these assays or may reflect variations in the sensitivity of each assay to inhibition by Nasal.
DISCUSSION
This study showed that salicylates inhibited LPS-induced TF expression in human monocytic cells. This inhibition was observed with Nasal, salsalate, and aspirin, indicating that both nonacetylated and acetylated salicylates share a common pathway in their ability to inhibit TF expression. Nasal inhibited LPS induction of TF activity, TF mRNA, and TF gene transcription but did not prevent PMA induction of EGR-I mRNA expression, indicating that it was not a general inhibitor of transcriptional activation. In addition, Nasal arthritis in which increased levels of TF are found in the synovium of patients: In addition, TF protein and mRNA are expressed by macrophage-derived foam cells in atherosclerotic plaques.' Both of these diseases are treated clinically with salicylates: therefore, the ability of salicylates to inhibit TF expression by monocytes may contribute to their efficacy and antithrombotic properties.
Cell surface expression of TF by monocyte/macrophages and secretion of various cytokines, including TNFa, are associated with the pathology of Gram-negative ~epsis."."~'~ An effective clinical inhibitor of transcriptional activation of TF and cytokine genes could be useful in the treatment of sepsis. In this study, we found that Nasal inhibited LPSinduced transcription of both the TF and TNFa genes in THP-I monocytic cells. Aspirin has previously been examined in rat and nonhuman primate models of endotoxemia with beneficial resultsJ".JX; however, no follow-up studies assessed its clinical use in sepsis therapy. Another NSAID, ibuprofen, has been extensively studied in relation to sepsis the rap^.^' Ibuprofen clearly reduces certain symptoms observed during septic shock, such as increased cardiac output, The dose-dependent inhibition (96) (mean t SDI was calculated from at least two independent experiments. Nasal concentrations inhibiting 50% of the LPS activation of c-ReVp65 and LPS-induced TF expression (IC5,,) were determined from linear regression (Microsoft Excel; Microsoft Corp. Bothell, WA). elevated mean arterial blood pressure, and end products of the cyclooxygenase pathway?' In contrast, endotoxin-induced elevation of the W-&-regulated genes interleukin-6
and TNFa were not decreased by ibuprofen administration.s0 Indomethacin, another NSAID, which (like ibuprofen) inhibits cyclooxygenase, was unable to inhibit transcription of the human immunodeficiency virus.36 Our data and those of others36 show that ibuprofen and indomethacin failed to inhibit activation of NF-KBRel proteins, which is consistent with their inability to reduce transcription of NF-KB/Relregulated genes." Sepsis is a complex pathological conditio# that will most likely require a well-defined multipledrug treatment for effective therapy. Given the new findings in relation to the modes of action observed with salicylates, it seems their use in sepsis therapy should be reexamined.
W-KB/Rel proteins regulate the activation of many genes that are induced during inflammatory responses, including genes encoding various cytokines and adhesion molecule^.^^ LPS induction of these genes is mediated by KB binding site^.^.^^ Therefore, inhibiting the activation of NF-KB/Rel proteins, especially in monocytes, may account for many of the anti-inflammatory effects of the salicylates.
